Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: Odronextamab Treatment of diffuse large B-cell lymphoma, 18/07/2022 Positive
TO:
Please use this form to send email to PR contact of this press release:
Orphan designation: Odronextamab Treatment of diffuse large B-cell lymphoma, 18/07/2022 Positive
TO: